Clinical Trial Update: pReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating preoperative dostarlimab and other novel therapies for endometrial cancer, which is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Dostarlimab (dostarlimab)

Snippet

Sponsor: University College, London | Conditions: Endometrial Cancer | Phase 2 | Status: NOT_YET_RECRUITING